Skip to main content

Spring Deadline: Sunday, March 1 @ 11:59pm PT. Click here to apply.

Differentiation of Acute Disseminated Encephalomyelitis from Multiple Sclerosis Using a Novel Brain Lesion Segmentation and Classification Pipeline

Differentiation of Acute Disseminated Encephalomyelitis from Multiple Sclerosis Using a Novel Brain Lesion Segmentation and Classification Pipeline

December 1, 2024

Only 17% of ADEM cases are correctly diagnosed on the first visit due to overlapping clinical and radiological presentations with Multiple Sclerosis. Our novel Classifier for Demyelinating Disease (CD...

Accepted to IEEE BHI 2024

Authors: Osama Radi, Aiden Huang, Kira Murukami

Only 17% of ADEM cases are correctly diagnosed on the first visit due to overlapping clinical and radiological presentations with Multiple Sclerosis. Our novel Classifier for Demyelinating Disease (CDD) pipeline is the first to differentiate ADEM from MS using MRI imagery. The pipeline combines brain lesion segmentation with machine learning classification to achieve accurate differentiation between these two demyelinating conditions. [arXiv link TBA]

Begin Your Journey

The application takes 10 minutes and is reviewed on a rolling basis. We look for strong technical signal—projects, coursework, or competition results—and a genuine curiosity to do real research.

If admitted, you will join a structured pipeline with direct mentorship to take your work from ideation to top conference submission at venues like NeurIPS, ACL, and EMNLP.